Palatin Technologies Inc (PTN)
1.72
-0.01
(-0.58%)
USD |
NYAM |
Apr 25, 16:00
1.74
+0.02
(+1.16%)
After-Hours: 20:00
Palatin Technologies Enterprise Value: 18.27M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | 18.27M |
April 24, 2024 | 18.43M |
April 23, 2024 | 18.75M |
April 22, 2024 | 18.27M |
April 19, 2024 | 20.21M |
April 18, 2024 | 21.01M |
April 17, 2024 | 21.17M |
April 16, 2024 | 20.69M |
April 15, 2024 | 19.88M |
April 12, 2024 | 21.50M |
April 11, 2024 | 22.79M |
April 10, 2024 | 20.69M |
April 09, 2024 | 24.08M |
April 08, 2024 | 23.11M |
April 05, 2024 | 18.92M |
April 04, 2024 | 18.59M |
April 03, 2024 | 17.95M |
April 02, 2024 | 18.27M |
April 01, 2024 | 18.92M |
March 28, 2024 | 20.69M |
March 27, 2024 | 16.33M |
March 26, 2024 | 16.66M |
March 25, 2024 | 15.04M |
March 22, 2024 | 15.53M |
March 21, 2024 | 16.66M |
Date | Value |
---|---|
March 20, 2024 | 15.85M |
March 19, 2024 | 15.69M |
March 18, 2024 | 16.33M |
March 15, 2024 | 15.37M |
March 14, 2024 | 14.72M |
March 13, 2024 | 16.33M |
March 12, 2024 | 17.46M |
March 11, 2024 | 18.11M |
March 08, 2024 | 20.21M |
March 07, 2024 | 21.01M |
March 06, 2024 | 20.53M |
March 05, 2024 | 22.30M |
March 04, 2024 | 22.47M |
March 01, 2024 | 26.02M |
February 29, 2024 | 22.95M |
February 28, 2024 | 30.05M |
February 27, 2024 | 54.58M |
February 26, 2024 | 48.93M |
February 23, 2024 | 41.02M |
February 22, 2024 | 41.99M |
February 21, 2024 | 38.60M |
February 20, 2024 | 42.80M |
February 16, 2024 | 39.25M |
February 15, 2024 | 41.35M |
February 14, 2024 | 57.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.910M
Minimum
Mar 18 2020
314.54M
Maximum
May 16 2019
55.94M
Average
41.48M
Median
Oct 25 2021
Enterprise Value Benchmarks
Oragenics Inc | 3.172M |
Outset Medical Inc | 46.99M |
Ligand Pharmaceuticals Inc | 1.076B |
Galectin Therapeutics Inc | 264.97M |
ADMA Biologics Inc | 1.549B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -7.844M |
Revenue (Quarterly) | 2.034M |
Total Expenses (Quarterly) | 8.684M |
EPS Diluted (Quarterly) | -0.56 |
Gross Profit Margin (Quarterly) | 95.20% |
Profit Margin (Quarterly) | -385.6% |
Earnings Yield | -151.7% |
Normalized Earnings Yield | -147.03 |